Impact of hormone replacement therapy on serum thyroid-stimulating hormone: a retrospective analysis
Reproductive BioMedicine Online · 2025
DOI: 10.1016/j.rbmo.2025.105045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2025. Verfasst von Pietro Molinaro und 6 weiteren Autor:innen. Beteiligte Einrichtung: IVIRMA Global Research Alliance, IVI Roma, Rome, Italy.; University of Valencia, Valencia, Spain. Hauptthemen laut MEDLINE: Thyrotropin, Hormone Replacement Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
RESEARCH QUESTION: What is the impact of hormone replacement therapy (HRT) on serum thyroid-stimulating hormone (TSH) during endometrial preparation for single-embryo transfer (SET)? DESIGN: This retrospective cohort study included 516 women (≤49 years) who underwent SET with either autologous or donor oocytes, between January 2022 and January 2023 at IVI Rome. TSH was measured at baseline (T0), during endometrial thickness assessment (T1), on embryo transfer day (T2), and at the pregnancy test (T3). TSH >2.5 mU/l was treated with levothyroxine. HRT consisted of oral estradiol valerate (6 mg/day) followed by vaginal progesterone (800 mg/day). RESULTS: TSH significantly increased at T1 and T3 compared to T0 (TSH0 1.67 mU/l, 95%CI 1.59-1.74; TSH1 1.93 mU/l, 95%CI 1.83-2.04, p 2.5 mU/l and pregnancy (aOR 0.64, 95%CI 0.36-1.14, p=0.13) or miscarriage (aOR 1.78, 95%CI 0.87-3.66, p = 0.11), while negative association was observed between TSH >2.5 mU/l and live birth (aOR 0.54, 95%CI 0.32-0.92, p = 0.02). CONCLUSIONS: HRT significantly increased TSH concentrations. Additionally, a TSH >2.5 mU/l did not correlate with miscarriage, but it was significantly associated with lower live birth rates. Further studies are needed to clarify HRT's impact on thyroid function and reproductive outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IVIRMA Global Research Alliance, IVI Roma, Rome, Italy.; University of Valencia, Valencia, Spain.
- IVIRMA Global Research Alliance, IVI Roma, Rome, Italy.
- University of Campania Luigi Vanvitelli, Caserta, Italy.
- IVIRMA Global Research Alliance, IVI Roma, Rome, Italy.; IVIRMA Global Research Alliance, IVI Foundation-IIS la Fe, Valencia, Spain.
- IVIRMA Global Research Alliance, IVI Roma, Rome, Italy.; IVIRMA Global Research Alliance, IVI Foundation-IIS la Fe, Valencia, Spain.. Electronic address: mauro.cozzolino@ivirma.com.
Zitieren
APA
Molinaro, P., Pellegrini, L., Mariani, G., Fasulo, D. D., Galliano, D., Pellicer, A., & Cozzolino, M. (2025). Impact of hormone replacement therapy on serum thyroid-stimulating hormone: a retrospective analysis. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2025.105045
Vancouver
Molinaro P, Pellegrini L, Mariani G, Fasulo DD, Galliano D, Pellicer A, et al. Impact of hormone replacement therapy on serum thyroid-stimulating hormone: a retrospective analysis. Reproductive BioMedicine Online. 2025. doi:10.1016/j.rbmo.2025.105045
BibTeX
@article{Molinaro2025,
author = {Molinaro, Pietro and Pellegrini, Livia and Mariani, Giulia and Fasulo, Diego D and Galliano, Daniela and Pellicer, Antonio and Cozzolino, Mauro},
title = {Impact of hormone replacement therapy on serum thyroid-stimulating hormone: a retrospective analysis},
journal = {Reproductive BioMedicine Online},
year = {2025},
doi = {10.1016/j.rbmo.2025.105045}
}
EUVIMED